Washington: The FDA may set up a “behind the counter” system letting more drugs, which presently need a recommendation to be sold without one.
In a perceive set to be released in today’s Federal Register, the agency declared a Nov. 14 hearing to explore "the public health benefit of drugs being available without a prescription but only after intervention by a pharmacist."